LSB-hsa-miR-223-3p Citations (1)

Originally described in: A mixed antagonistic/synergistic miRNA repression model enables accurate predictions of multi-input miRNA sensor activity.
Gam JJ, Babb J, Weiss R Nat Commun. 2018 Jun 22;9(1):2430. doi: 10.1038/s41467-018-04575-0. PubMed Journal

---

Articles Citing LSB-hsa-miR-223-3p

Articles
Implications of NLRP3 Suppression Using Glibenclamide and miR-223 against Colorectal Cancer. Hamza S, Garanina EE, Shkair L, Alsaadi M, Khaiboullina SF, Tezcan G. Pharmaceuticals (Basel). 2024 Feb 26;17(3):299. doi: 10.3390/ph17030299. PubMed

If you have published an article using this material, please email us at to have your article added to this page.